VIR logo

VIR
Vir Biotechnology Inc

6,818
Mkt Cap
$1.61B
Volume
1.59M
52W High
$11.66
52W Low
$4.16
PE Ratio
-3.16
VIR Fundamentals
Price
$10.29
Prev Close
$10.01
Open
$10.09
50D MA
$9.63
Beta
1.64
Avg. Volume
1.8M
EPS (Annual)
-$3.16
P/B
1.82
Rev/Employee
$186,801.09
$464.19
Loading...
Loading...

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available
Poll

Earnings Recap

• Reported GAAP EPS of -$0.85 up 3.41% YoY • Reported revenue of -$0.03M down -100.96% YoY • Vir Biotechnology expects its cash, cash equivalents and investments, including effects of the Astellas collaboration and equity financing, to fund operations into the second half of 2028.

Bullish

Vir Biotechnology demonstrated strong financial health and advanced its pipeline with a key Astellas collaboration for VIR-5500 and positive Phase 2 data for its CHD combination regimen.

Bearish

Vir Biotechnology experienced an increased net loss and a significant decline in total revenues during Q1 2026, alongside the inherent high risks of drug development and commercialization.

Latest VIR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.